𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pattern of parvovirus B19 infection during different trimesters of pregnancy in Kuwait

✍ Scribed by Ma'asoumah Makhseed; Alexander Pacsa; Mohammad Abrar Ahmed; Sahar Sultan Essa

Publisher
Hindawi Publishing Corporation
Year
1999
Tongue
English
Weight
141 KB
Volume
7
Category
Article
ISSN
1064-7449

No coin nor oath required. For personal study only.

✦ Synopsis

Objective: Aims of this study were to determine the IgG and IgM seropositivity to parvovirus B19 during the three trimesters of pregnancy.

Methods: Initially, a total of 1,047 pregnant women were included in a prospective study. Blood samples were obtained from 343, 406 and 298 cases in the first, second and third trimesters, respectively. To study the incidence of seroconversion, a second sample of blood was obtained 2-4 weeks later from the first 100 cases, who were IgG and IgM negative in the first trimester.

Results: The seroprevalence of parvovirus B19 IgG and IgM was 53.3% and 2.2%, respectively. The incidence of seroconversion was 16.5%. The rate of fetal loss was 15.4% in patients with acute infection, all of which occurred in the first two trimesters.

Conclusions: The percentage of IgG positive cases is significantly higher in first and second trimesters compared to the third trimester. The seroconversion rate was 16.5%.

πŸ“œ SIMILAR VOLUMES

Parvovirus B19 quiescence during the cou
Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia
✍ Goedert, James J.; Erdman, Dean D.; Konkle, Barbara A.; TΓΆrΓΆk, Thomas J.; Lederm πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 28 KB πŸ‘ 2 views

To detect and characterize parvovirus B19 infection during the course of progressive immune deficiency from human immunodeficiency virus (HIV), ten subjects enrolled in the Multicenter Hemophilia Cohort Study were followed for 6.4 to 15 years from HIV seroconversion through extreme immune deficiency

Seroprevalence of parvovirus B19 NS1-spe
Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women
✍ Hemauer, Andrea; Gigler, Andreas; Searle, Karen; Beckenlehner, Karin; Raab, Ulla πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

Parvovirus B19 is the causative agent of erythema infectiosum in children, but the virus is associated with an increasing range of different diseases. These include acute and chronic arthritis, hydrops fetalis in pregnant women, aplastic anemia, and thrombocytopenia. The host's immune response is di

Development of antibodies to the nonstru
Development of antibodies to the nonstructural Protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: Implications for pathogenesis doubtful
✍ Searle, Karen; Schalasta, Gunnar; Enders, Gisela πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 1 views

At present little is known about the mechanisms influencing the course and severity of parvovirus B19 infection. Antibodies to the parvovirus nonstructural protein NS1 were reported in patients with parvovirus-associated arthritis and those with persisting infection but not in those without complica

Standardization of a PCR-ELISA in serum
Standardization of a PCR-ELISA in serum samples: Diagnosis of active parvovirus B19 infection
✍ Zerbini, Marialuisa; Gallinella, Giorgio; Manaresi, Elisabetta; Musiani, Monica; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 1 views

To standardize a PCR assay for the detection of parvovirus B19 DNA in serum samples three different sample treatments were evaluated on the basis of the efficiency of recovery, reproducibility, convenience of sample handling, and presence of PCR inhibitors. Moreover, the presence of an internal stan